Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00348634 · ClinicalTrials.gov registry record · Phase 4
Effect of Tegaserod on Orocecal Transit in Elderly Chronic Constipation Patients
A Phase 4 study, sponsored by Novartis.
- Terminated
- Registry status
- Phase 4
- Development phase
- 60
- Enrollment target
NCT00348634: Clinical Trial Phase 4 study, sponsored by Novartis.
NCT00348634 is a Phase 4 study that was terminated before completion, run by Novartis. The registered enrollment target is 60 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (88% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00348634, a Phase 4 study, was terminated before completion, sponsored by Novartis.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 60 participants
- Enrollment target
Study Summary
This study will evaluate the effects of tegaserod on orocecal and colonic transit in patients over 65 years with chronic constipation.
Interventions
- DRUG Tegaserod
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2006-07 |
| Est. Completion | 2007-04 |
| Phase | Phase 4 |
Why NCT00348634 stopped before completion
NCT00348634 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (88% lower).
The record links to 0 conditions, and to 1 intervention - of which Tegaserod is the first listed.
NCT00348634 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00348634 about?
NCT00348634 is a clinical study titled "Effect of Tegaserod on Orocecal Transit in Elderly Chronic Constipation Patients". This study will evaluate the effects of tegaserod on orocecal and colonic transit in patients over 65 years with chronic constipation.
What is the current status of trial NCT00348634?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 60 participants. The study started on 2006-07. Estimated completion is 2007-04.
What interventions are being tested in trial NCT00348634?
The interventions under investigation include: Tegaserod (DRUG).
Who is sponsoring clinical trial NCT00348634?
This trial is sponsored by Novartis, which has 265 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00348634's enrollment target sits among peer trials
60 1125th of 2000 higher than 799 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia